Keyphrases
Hispanic
100%
Cost-effectiveness
100%
Kidney Transplant Recipients
100%
Once-daily
100%
Twice-daily Tacrolimus
100%
Immediate-release Tacrolimus
100%
Hispanic Population
33%
Serious Adverse Events
33%
Treatment-related
33%
Graft Failure
33%
First Year
16%
Direct Costs
16%
Black Men
16%
Phase III Clinical Trial
16%
Hispanic Patients
16%
Overall Effectiveness
16%
Decision-analytic Model
16%
Patient Demographics
16%
Twice Daily
16%
Dialysis
16%
Overall Cost
16%
Immunosuppressive Therapy
16%
Biopsy-proven Rejection
16%
Tacrolimus
16%
Identified Parameters
16%
Prolonged-release Tacrolimus
16%
Payer Perspective
16%
Metabolizer
16%
Rejection Treatment
16%
Probabilistic Sensitivity Analysis
16%
One-way Sensitivity Analysis
16%
Pharmacology, Toxicology and Pharmaceutical Science
Tacrolimus
100%
Adverse Event
22%
Graft Failure
22%
Clinical Trial
11%
Immunosuppressive Agent
11%
Tablet
11%
Acute Graft Rejection
11%